NYSEIndustrialsAerospace & DefenseSnapshot 2026-10-15
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
View Living FV report and workflow4 key conditions need to be met for the investment thesis to play out.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
2026 EPS at least $6.4 per share | Profit per share is expected near $6.5. | Under Pressure | EPS falls below $6.0 per share in 2026 | Diluted EPS: $1.42 per share FY2027-Q2; GAAP. Published target: >= $6.4 per share. Target period is not explicitly aligned with this observation. Source published Jul 28, 20261.42 USD/share · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2027-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2027-Q2. Source status: unverified. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsThe evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Oct 29, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a turnaround story with elements of a durable compounder. The current thesis is cautious, given the mixed execution quality and sector challenges.
The market appears to price in a low level of fragility, reflecting a cheap valuation compared to peers. However, there is a significant expectations gap, suggesting that investors are not fully accounting for potential risks.
Management is focused on increasing revenue and improving cash flow, with recent results showing some positive trends. However, the earnings quality remains fragile, indicating that execution will be critical in the near term.
The future performance of TXT hinges on the outcomes of its strategic initiatives, particularly the separation of its Industrial segment. Additionally, the stock's trajectory will be influenced by the performance of sector bellwethers like SPCX, GE, and RTX.
In the next 1-3 years, TXT's success will depend on effective management execution and external sector conditions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Successful separation of Industrial segment | A supporting condition in Textron's published investment case. The stated target is Industrial segment separated by end 2026. | Intact | Separation delayed beyond 2026 or fails to enhance value | Separation process active vs end-2026 target Textron is self-funding the MV-75 while actively pursuing the Industrial segment sale process, maintaining the timeline for separation by end-2026. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. Management announced the intent to separate the Industrial segment in 2026-Q1 and initiated the sale process by 2026-Q2. This strategic move is ongoing with no financial results yet reported from the separation, indicating early-stage execution. Delivery assessment Oct 15, 2026 |
Manufacturing cash flow before pension contributions between $700M and $800M | Cash flow from manufacturing should reach $700 million to $800 million. | Improving | Manufacturing cash flow falls below $700 million in 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 5 of last 5 quarters. Manufacturing cash flow before pension contributions was $969 million in 2025 full year, declined to a negative $228 million in 2026-Q1, then improved to $154 million in 2026-Q2. Management reiterated a 2026 target range of $700 million to $800 million, showing mixed but improving cash flow performance. Delivery assessment Oct 15, 2026 |
2026 revenue reaches at least $15.5 billion | A primary condition in Textron's published investment case. The stated target is >= $15.5 billion. | Under Pressure | 2026 revenue falls below $14.8 billion | Revenue: $3.827B FY2027-Q2; GAAP. Published target: >= $15.5 billion. Target period is not explicitly aligned with this observation. Source published Jul 28, 20263,827,000,000 USD · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2027-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2027-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 5 of last 5 quarters. Revenue grew from $14.8 billion in 2025 to a forecast of $15.5 billion in 2026. Quarterly revenues increased from $3.3B in 2025-Q1 to $3.7B in 2026-Q1 (+12%) and $3.7B in 2025-Q2 to $3.8B in 2026-Q2 (+3%). The trajectory is delivering consistent revenue growth aligned with management's guidance. Delivery assessment Oct 15, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
| Date | Buy* | Hold | Sell* |
|---|---|---|---|
| 2026-05-01 | 6 | 12 | 0 |
| 2026-06-01 | 6 | 11 | 0 |
| 2026-07-01 | 7 | 11 | 0 |
| 2026-08-01 | 7 | 10 | 0 |
| 2026-09-01 | 7 | 9 | 0 |
| 2026-10-01 | 7 | 9 | 0 |
*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.
Latest: 7 Buy / Strong Buy · 9 Hold · 0 Sell / Strong Sell
Recent actions · Sep 16–Oct 15 · 2 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.